We've found
5,401
archived clinical trials in
Alzheimer Disease
We've found
5,401
archived clinical trials in
Alzheimer Disease
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
Updated: 12/31/1969
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
Updated: 12/31/1969
Phase 1 Pharmacokinetic (PK) Study to Evaluate Once-weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept® in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
Updated: 12/31/1969
Phase 1 Pharmacokinetic (PK) Study to Evaluate Once-weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept® in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Updated: 12/31/1969
A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
